Garcia Guillermo Garcia, Harden Paul, Chapman Jeremy
Nephrology Service, Hospital Civil de Guadalajara, University of Guadalajara Health Sciences Center Hospital 278, Guadalajara, Jal. 44280, Mexico.
Oxford Kidney Unit and Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom.
J Nephropathol. 2012 Jul;1(2):69-76. doi: 10.5812/nephropathol.7448. Epub 2012 Jul 1.
World Kidney Day on March 8th 2012 provides a chance to reflect on the success of kidney transplantation as a therapy for end stage kidney disease that surpasses dialysis treatments both for the quality and quantity of life that it provides and for its cost effectiveness. Anything that is both cheaper and better, but is not actually the dominant therapy, must have other drawbacks that prevent replacement of all dialysis treatment by transplantation. The barriers to universal transplantation as the therapy for end stage kidney disease include the economic limitations which, in some countries place transplantation, appropriately, at a lower priority than public health fundamentals such as clean water, sanitation and vaccination. Even in high income countries the technical challenges of surgery and the consequences of immunosuppression restrict the number of suitable recipients, but the major finite restrictions on kidney transplantation rates are the shortage of donated organs and the limited medical, surgical and nursing workforces with the required expertise. These problems have solutions which involve the full range of societal, professional, governmental and political environments. World Kidney Day is a call to deliver transplantation therapy to the one million people a year who have a right to benefit.
2012年3月8日的世界肾脏日提供了一个契机,让我们反思肾脏移植作为终末期肾病治疗方法所取得的成功。与透析治疗相比,肾脏移植在提高患者生活质量和延长寿命方面以及在成本效益方面都更具优势。任何一种既更便宜又更好,但却并非主导治疗方法的事物,必然存在其他阻碍其完全取代透析治疗的弊端。将肾脏移植作为终末期肾病的普遍治疗方法存在诸多障碍,其中包括经济限制,在一些国家,与清洁水源、卫生设施和疫苗接种等公共卫生基本要素相比,肾脏移植被合理地置于较低优先级。即便在高收入国家,手术的技术挑战以及免疫抑制的后果也限制了合适受者的数量,但对肾脏移植率的主要限制因素是捐赠器官的短缺以及具备所需专业知识的医学、外科和护理人员的有限。这些问题是有解决办法的,涉及社会、专业、政府和政治等各个环境。世界肾脏日呼吁每年为100万有权受益的人提供移植治疗。